Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “HALOZYME, INC.”

69 pharma patents match "HALOZYME, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 69
Index total 30,257
Page 3 / 3

Quick answer

This filtered view shows 69 pharmaceutical patents matching "HALOZYME, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

69 results for “HALOZYME, INC.” · 30,257 patents in full index Clear search

  1. US 8846034

    Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof

    HALOZYME, INC. · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted
  2. US 8815558

    Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereof

    HALOZYME, INC. · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted
  3. US 8772246

    Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof

    HALOZYME, INC. · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  4. US 8765685

    Methods for treating edema by administering a Soluble Hyaluronidase Glycoprotein (sHASEGP)

    HALOZYME, INC. · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  5. US 8580252

    Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

    HALOZYME, INC. · Granted Nov 12, 2013 · Expires Nov 7, 2033

    granted
  6. US 8568713

    Super fast-acting insulin compositions

    HALOZYME, INC. · Granted Oct 29, 2013 · Expires Oct 24, 2033

    granted
  7. US 8450470

    Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof

    HALOZYME, INC. · Granted May 28, 2013 · Expires May 23, 2033

    granted
  8. US 8431124

    Methods for treating a disease characterized by an excess of hyaluronan by administering a soluble hyaluronidase glycoprotein (sHASEGP)

    HALOZYME, INC. · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted
  9. US 8431380

    Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof

    HALOZYME, INC. · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted
  10. US 8318154

    Super fast-acting insulin compositions

    HALOZYME, INC. · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted
  11. US 8257699

    Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

    HALOZYME, INC. · Granted Sep 4, 2012 · Expires Aug 30, 2032

    granted
  12. US 8202517

    Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof

    HALOZYME, INC. · Granted Jun 19, 2012 · Expires Jun 14, 2032

    granted
  13. US 8105586

    Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

    HALOZYME, INC. · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted
  14. US 7871607

    Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

    HALOZYME, INC. · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted
  15. US 7846431

    Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

    HALOZYME, INC. · Granted Dec 7, 2010 · Expires Dec 2, 2030

    granted
  16. US 7829081

    Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

    HALOZYME, INC. · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted
  17. US 7786096

    Inhibition of antigen presentation with poorly catabolized polymers

    HALOZYME, INC. · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted
  18. US 7767429

    Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof

    HALOZYME, INC. · Granted Aug 3, 2010 · Expires Jul 29, 2030

    granted
  19. US 7718428

    Myeloid colony stimulating factor and uses thereof

    HALOZYME, INC. · Granted May 18, 2010 · Expires May 13, 2030

    granted
  20. US 7544499

    Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereof

    HALOZYME, INC. · Granted Jun 9, 2009 · Expires Jun 4, 2029

    granted
  21. US 7538097

    Inhibition of antigen presentation with poorly catabolized polymers

    HALOZYME, INC. · Granted May 26, 2009 · Expires May 21, 2029

    granted